Colitis-associated cancer: The dark side of inflammatory bowel disease

Gut

Volumn 60, Issue 12, 2011, Pages 1609-1610

  Danese, Silvio ^a   Malesci, Alberto ^a,b   Vetrano, Stefania ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 21; INTERLEUKIN 23;

ADAPTIVE IMMUNITY; CANCER RISK; COLON CARCINOGENESIS; COLORECTAL CANCER; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; ENTERITIS; HUMAN; INFLAMMATION; INFLAMMATORY INFILTRATE; MALIGNANT TRANSFORMATION; NOTE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TRANSCRIPTION REGULATION; TUMOR MICROENVIRONMENT;

ANIMALS; COLITIS; COLONIC NEOPLASMS; IMMUNOLOGIC SURVEILLANCE; INTERLEUKINS;

EID: 80655148899     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-300953     Document Type: Note

References (11)

1. Mantovani A, Allavena P, Sica A, et al. Cancerrelated inflammation. Nature 2008;454:436-44.
2. Danese S, Mantovani A. Inflammatory bowel disease and intestinal cancer: a paradigm of the YineYang interplay between inflammation and cancer. Oncogene 2010;29:3313-23.
3. Phillips RK, Wallace MH, Lynch PM, et al. A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut 2002;50:857-60.
4. Mantovani A. Cancer: inflaming metastasis. Nature 2009;457:36-7.
5. Swann JB, Smyth MJ. Immune surveillance of tumors. J Clin Invest 2007;117:1137-46. (Pubitemid 46718398)
6. Kastelein RA, Hunter CA, Cua DJ. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol 2007;25:221-42. (Pubitemid 46697908)
7. Deenick EK, Tangye SG. Autoimmunity: IL-21: a new player in Th17-cell differentiation. Immunol Cell Biol 2007;85:503-5. (Pubitemid 47530594)
8. Annunziato F, Cosmi L, Santarlasci V, et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007;204:1849-61. (Pubitemid 47240944)
9. Wilke CM, Kryczek I, Wei S, et al. Th17 cells in cancer: help or hindrance? Carcinogenesis 2011;32:643-9.
10. Fina D, Sarra M, Fantini MC, et al. Regulation of gut inflammation and th17 cell response by interleukin-21. Gastroenterology 2008;134:1038-48.
11. Jauch D, Martin M, Schiechl G, et al. Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumourigenesis in mice. Gut 2011;66:1678-86.